Related references
Note: Only part of the references are listed.Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Less label, more free: Approaches in label-free quantitative mass spectrometry
Karlie A. Neilson et al.
PROTEOMICS (2011)
TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer
Norikatsu Miyoshi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor
Michael K. Connolly et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Comparative Protein Profiling Reveals Minichromosome Maintenance (MCM) Proteins As Novel Potential Tumor Markers for Meningiomas
Okay Saydam et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Subnuclear Proteomics in Colorectal Cancer IDENTIFICATION OF PROTEINS ENRICHED IN THE NUCLEAR MATRIX FRACTION AND REGULATION IN ADENOMA TO CARCINOMA PROGRESSION
Jakob Albrethsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Subsets, expansion and activation of myeloid-derived suppressor cells
Eliana Ribechini et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice
Lisa Sevenich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study
Khalid A. Tazi et al.
HEPATOLOGY RESEARCH (2009)
The Role of Cathepsins in Involution and Breast Cancer
Christine J. Watson et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
IDPicker 2.0: Improved Protein Assembly with High Discrimination Peptide Identification Filtering
Ze-Qiang Ma et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases
Adaikkalam Vellaichamy et al.
PLOS ONE (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
Refractoriness to antivascular endothelial growth factor treatment: Role of myeloid cells
Farbod Shojaei et al.
CANCER RESEARCH (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
What's driving false discovery rates?
David L. Tabb
JOURNAL OF PROTEOME RESEARCH (2008)
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma
Toshimichi Asano et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Tissue transglutaminase-mediated chemoresistance in cancer cells
Amit Verma et al.
DRUG RESISTANCE UPDATES (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
MyriMatch: Highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis
David L. Tabb et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Role of von Willebrand factor in tumor metastasis
Virginie Terraube et al.
THROMBOSIS RESEARCH (2007)
Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells
Shivalingappa Venkatesha et al.
MOLECULAR CANCER RESEARCH (2006)
Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease
Melissa Kristine Middleton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Predicting disease genes using protein-protein interactions
M. Oti et al.
JOURNAL OF MEDICAL GENETICS (2006)
Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer
Fu-Yen Chung et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Macrophage elastase (matrixmetalloproteinase-12) suppresses growth of lung metastases
A. McGarry Houghton et al.
CANCER RESEARCH (2006)
WebGestalt: an integrated system for exploring gene sets in various biological contexts
B Zhang et al.
NUCLEIC ACIDS RESEARCH (2005)
Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells
J Hanai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment
BF Sloane et al.
SEMINARS IN CANCER BIOLOGY (2005)
Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer
K Mehta et al.
CLINICAL CANCER RESEARCH (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
Thrombospondin-1 and cutaneous melanoma
MJ Trotter et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2003)
Shotgun identification of protein modifications from protein complexes and lens tissue
MJ MacCoss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver
E Obrador et al.
HEPATOLOGY (2002)
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
JC Rodríguez-Manzaneque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
